Cyclophosphamide Capsule
Product Images NDC 0054-0382

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cyclophosphamide (NDC 0054-0382). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bl 25mg 10008218 05

Each capsule contains 25 mg of cyclophosphamide 5P (selected as anhydrous). The usual dosage should be seen on the package insert for complete prescribing information. The capsules should be swallowed whole and should not be opened, chewed, or crushed. The capsules can be stored at 20°C to 25°C (66°F to 77°F) and excursions are permitted between 15°C to 30°C (50°F to 86°F). The drug is dispensed in a tight container as defined in the LSPAF. This is a cytotoxic agent and it is recommended to wear gloves when handling the container and capsules. Distributed by West-Ward Pharmaceuticals Corp. NDC 0054-0382-25 100 Capsules.*

FDA Label Image

Bl 50mg 10008217 05

Each capsule contains 50mg of cyclophosphamide as NDG 0054-0383-25 anhydrous USP. It is distributed by West-Ward Pharmaceuticals Corp. and comes in a container with 100 capsules. The usual dosage is indicated in the package insert, and it is classified as a cytotoxic agent. Handle the capsules with gloves, and do not open, chew, or crush them. Store the container at room temperature between 20°C to 25°C, with excursions permitted between 15°C to 30°C. Dispense the capsules in a tight container as defined in USP/NF.*

FDA Label Image

Chem Struc (Image 01)

Not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.